Vytorin

   
Google
 
Web NewDrugInformation.com

Vytorin


Drug - Vytorin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ezetimibe; Simvastatin
Multiple ingredients are in alphabetical order.

Strength - 10MG;20MG
The potency of the active ingredient(s), Ezetimibe; Simvastatin. May repeat for multiple part products.

Applicant - MSP SINGAPORE
The firm name holding legal responsibility for Vytorin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021687
The FDA assigned number to Vytorin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Vytorin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 23, 2004
The date Vytorin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Vytorin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Vytorin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Msp Singapore Co Llc
The full name of the firm holding legal responsibility for the new application of Vytorin.

Vytorin